Skip to main content
Back to Creative Destruction Lab

Creative Destruction Lab's Pharmaceutical Portfolio

Browse 13 Pharmaceutical companies funded by Creative Destruction Lab. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
13
Total Funding in Pharmaceutical
$62.9M

Pharmaceutical Portfolio Companies (13)

Export
AnalyticsBiotechnologyHealth CarePharmaceutical

DrugBank is a provider of drug information and insight generation tools that accelerate drug research and improve healthcare delivery.

Edmonton, Canada
August 2023
$715K
Grant

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BioinformaticsCloud ComputingEnterprise SoftwareGenerative AIHealth CareLife SciencePharmaceuticalPredictive AnalyticsSoftware

Altis helps biopharma run faster & more successful clinical trials using AI models trained on the industry's richest multimodal database.

Toronto, Canada
June 2023
$6.0M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyChemicalHealth CareLife ScienceMachine LearningPharmaceuticalQuantum ComputingTherapeutics

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

Palo Alto, United States
May 2023
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

ProteinQure is a biotech company that designs peptide-based therapeutics and drug delivery systems using AI.

Toronto, Canada
May 2026
$1.8M
Grant

Founder Contacts

30,000+ verified contacts

ManufacturingMedical DevicePharmaceutical

Tidal Medical is a medical device company which created a new type of remote monitoring system for patients suffering from heart failure.

Toronto, Canada
May 2022
$30K
Grant

Founder Contacts

30,000+ verified contacts

BioinformaticsInformation ServicesInformation TechnologyPharmaceuticalSoftware

Computational Drug Discovery for Small-Molecule Teams

Kraków, Poland
February 2026
$3.5M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Regenosine is developing a disease-modifying regenerative therapy for osteoarthritis.

New Jersey, Trinidad and Tobago
February 2023
$25K
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Nia Therapeutics develops a precision neurostimulation therapy for the treatment of memory loss.

Radnor, United States
February 2024
$10.4M
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

Paradox Immunotherapeutics is a pharmaceutical company that develops treatments for patients suffering from rare amyloid diseases.

Toronto, Canada
February 2025
$10.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Dietary SupplementsEnterprise SoftwareFood and BeverageMiningNutritionPharmaceuticalSaaSSnack FoodSoftware

GMP-ready Manufacturing Operations Software for Regulated Industries

Vancouver, Canada
February 2024
$5.8M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Redesign Science is a computational chemistry company setting a new standard for early-stage, small molecule drug discovery.

New York, United States
December 2021
$15.0M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Machine LearningPharmaceuticalTherapeutics

Valence Discovery (“Valence”), is an AI-first design of novel chemistry against previously intractable biology.

Montréal, Canada
December 2021
$7.0M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Pharmaceutical

NetraMark is an AI and pharma-tech company, has developed proprietary solutions for pharmaceutical and biotechnology companies.

Toronto, Canada
January 2026
$2.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Explore Creative Destruction Lab's Full Portfolio

View all companies funded by Creative Destruction Lab across every industry and funding stage.

View Full Creative Destruction Lab Portfolio